COVID-19 Linked to Increased Risk for DVT, PE, Bleeding
Rate ratios were highest for critical COVID-19, and during first versus second and third pandemic waves in Sweden.
Rate ratios were highest for critical COVID-19, and during first versus second and third pandemic waves in Sweden.
Researchers sought to determine the predictors of mortality during hospital stays in patients with multiple myeloma.
Researchers sought to determine the risk factors for both venous and arterial thrombosis in neonates admitted to neonatal intensive care units.
Investigators compared outcomes of thrombolytic therapy and surgery as first-line treatment for patients with obstructive prosthetic valve thrombosis.
Researchers sought to determine the underlying reasons for thrombosis risk in patients with severe COVID-19.
Researchers sought to determine whether there is an association between INR and anticoagulation-related outcomes in an Asian population after AVR or MVR.
The objective of the study was to assess the association between psoriatic arthritis and venous thromboembolism events.
The updated CHEST guideline on antithrombotic therapy for VTE includes 4 new PICO questions as well as updated recommendations based on newer evidence.
Researchers sought to determine incidence of VTE and bleeding events for patients with CAT who switched to rivaroxaban treatment after at least 4 weeks of standard anticoagulation therapy.
Researchers sought to determine how the plasma level of complement C5 is related to the risk of developing VTE.